Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1.

Lennox, J L; Landovitz, R J; Ribaudo, H J; Ofotokun, I; Na, L H; Godfrey, C; Kuritzkes, D R; Sagar, M; Brown, T T; Cohn, S E; McComsey, G A; Aweeka, F; Fichtenbaum, C J; Presti, R M; Koletar, S L; Haas, D W; Patterson, K B; Benson, C A; Baugh, B P; Leavitt, R Y; Rooney, J F; Seekins, D; Currier, J S

Lennox, J L; Landovitz, R J; Ribaudo, H J; Ofotokun, I; Na, L H; Godfrey, C; Kuritzkes, D R; Sagar, M; Brown, T T; Cohn, S E; McComsey, G A; Aweeka, F; Fichtenbaum, C J; Presti, R M; Koletar, S L; Haas, D W; Patterson, K B; Benson, C A; Baugh, B P; Leavitt, R Y; Rooney, J F; Seekins, D; Currier, J S.

Ann Intern Med ; 161(7): I-22, 2014 Oct 07.

Article in En | MEDLINE | ID: mdl-25285557

Subject(s)

Anti-Retroviral Agents/therapeutic use; HIV Infections/drug therapy; HIV-1; Drug Therapy; Humans; Reverse Transcriptase Inhibitors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-Retroviral Agents Limits: Humans Language: En Journal: Ann Intern Med Year: 2014 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google